Webinar: Tech-Enabled Trials from eSource to Centralized Monitoring and Modern Patient Experiences
Register Now

The CRO Built for Sponsors

Run your trial with faster execution and higher quality. The Vial CRO leverages our Clinic Network of over 35 Clinics and CRO capabilities to provide our sponsors with faster, higher quality trial outcomes.

35+

Clinical Research Sites

750+

Trials Completed

6

Therapeutic Areas

Vial's vision
is to empower scientists to cure all human disease.

Vial's mission is to run clinical trials
with faster execution and higher quality
in order to bring new therapies to market.

We found our calling in clinical trials after learning the pain points directly. It is curiosity that propels us to keep building, finding new challenges, and fulfilling our vision of reimagining clinical trials.

Meet our Leadership Team

Our team merges an expertise in technology and CRO operations. We have built $1B+ technology products and have over 25 years experience managing best in class research sites.

Simon Burns

Simon Burns

Co-founder & Chief Executive Officer

Andrew Brackin

Andrew Brackin

Co-founder & Chief Revenue Officer

Betsey Zbyszynski

Betsey Zbyszynski

VP, Head of Dermatology

Marcia Swank

VP, Head of Ophthalmology

Janet DuBois

Janet DuBois, MD

Medical Director

Justin Withers

Justin Withers

Head of Dermatology (Site Network)

Danielle McNulty

Danielle McNulty

Director of Project Management

Tina Jiang

Tina Jiang

GM - Patients Experience

William MacInnis

Will MacInnis

VP Finance

Ananya Shah

Ananya Shah

Head of Business Operations

Carly Warner

Carly Warner

Head of People

Scientific Advisory Board

Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance research.

Dr Guru Sonpavde

Dr. Guru Sonpavde

Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard
Medical School

Dr Neeraj Agarwal

Dr. Neeraj Agarwal

Professor of Medicine and Presidential Endowed Chair of Cancer Research
at the Huntsman Cancer Institute, University of Utah

Dr.-Arshad-Khanani-MD-

Dr. Arshad Khanani

Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates

Dr. Mark Lebwohl

Dr. Mark Lebwohl

Waldman Professor and Chairman
of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the
Mount Sinai Hospital in New York City

Dr. Luke Nordquist

Dr. Luke Nordquist

CEO at Urology Cancer Center and XCancer Research

Dr Arvind Chaudhry

Dr. Arvind Chaudhry

Director of Summit Cancer Centers, Medical Oncologist

Dr Nancy Holekamp

Dr. Nancy Holekamp

Director of Retina Services
at the Pepose Vision Institute

Dr. David Pariser

Dr. David Pariser

Senior physician of Pariser Dermatology Specialist and Principal Investigator

Dr Arati Rao

Dr. Arati Rao

Head of Clinical Development at PACT Pharma

Dr. Antoni Ribas

Dr. Antoni Ribas

Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA)

Dr Jeffrey Heier

Dr. Jeffrey Heier

Director of the Vitreoretinal Service and Director of Retina Research at OCB

Merola_Joseph

Dr. Joseph Merola

Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School

Dr Peter Kaise

Dr. Peter Kaiser

Chaney Family Endowed Chair of Ophthalmic Research and a Professor of Ophthalmology at the Cleveland Clinic

Jonathan Zung

Dr. Jonathan Zung

Chief Development Officer at Evelo Biosciences

Running Trials?
Learn more about our Faster Execution and Higher Quality